Blake Kimberly V, Hilbert Kevin, Ipser Jonathan C, Han Laura K M, Bas-Hoogendam Janna Marie, Åhs Fredrik, Bauer Jochen, Beesdo-Baum Katja, Björkstrand Johannes, Blanco-Hinojo Laura, Böhnlein Joscha, Bülow Robin, Cano Marta, Cardoner Narcis, Caseras Xavier, Dannlowski Udo, Fredrikson Mats, Goossens Liesbet, Grabe Hans J, Grotegerd Dominik, Hahn Tim, Hamm Alfons, Heinig Ingmar, Herrmann Martin J, Hofmann David, Jamalabadi Hamidreza, Jansen Andreas, Kindt Merel, Kircher Tilo, Klahn Anna L, Koelkebeck Katja, Krug Axel, Leehr Elisabeth J, Lotze Martin, Margraf Juergen, Muehlhan Markus, Nenadić Igor, Peñate Wenceslao, Pittig Andre, Plag Jens, Pujol Jesús, Richter Jan, Ridderbusch Isabelle C, Rivero Francisco, Schäfer Axel, Schäfer Judith, Schienle Anne, Schrammen Elisabeth, Schruers Koen, Seidl Esther, Stark Rudolf M, Straube Benjamin, Straube Thomas, Ströhle Andreas, Teutenberg Lea, Thomopoulos Sophia I, Ventura-Bort Carlos, Visser Renee M, Völzke Henry, Wabnegger Albert, Wendt Julia, Wittchen Hans-Ulrich, Wittfeld Katharina, Yang Yunbo, Zilverstand Anna, Zwanzger Peter, Schmaal Lianne, Aghajani Moji, Pine Daniel S, Thompson Paul M, van der Wee Nic J A, Stein Dan J, Lueken Ulrike, Groenewold Nynke A
Department of Psychiatry and Mental Health, Neuroscience Institute, University of Cape Town, Cape Town, South Africa.
Department of Psychology, Health and Medical University Erfurt, Erfurt, Germany.
medRxiv. 2025 Mar 20:2025.03.19.25323474. doi: 10.1101/2025.03.19.25323474.
Specific phobia (SPH) is a prevalent anxiety disorder and may involve advanced biological aging. However, brain age research in psychiatry has primarily examined mood and psychotic disorders. This mega-analysis investigated brain aging in SPH participants within the ENIGMA-Anxiety Working Group.
3D brain tructural MRI scans from 17 international samples (600 SPH individuals, of whom 504 formally diagnosed and 96 questionnaire-based cases; 1,134 controls; age range: 22-75 years) were processed with FreeSurfer. Brain age was estimated from 77 subcortical and cortical regions with a publicly available ENIGMA brain age model. The brain-predicted age difference (brain-PAD) was calculated as brain age minus chronological age. Linear mixed-effect models examined group differences in brain-PAD and moderation by age.
No significant group difference in brain-PAD manifested ( (SE)=0.37 years (0.43), =0.39). A negative diagnosis-by-age interaction was identified, which was most pronounced in formally diagnosed SPH ( =-0.08 (0.03), =0.02). This interaction remained significant when excluding participants with anxiety comorbidities, depressive comorbidities, and medication use. Post-hoc analyses revealed a group difference for formal SPH diagnosis in younger participants (22-35 years; =1.20 (0.60), <0.05, mixed-effects (95% confidence interval)=0.14 (0.00-0.28)), but not older participants (36-75 years; =0.07 (0.65), =0.91).
Brain aging did not relate to SPH in the full sample. However, a diagnosis-by-age interaction was observed across analyses, and was strongest in formally diagnosed SPH. Post-hoc analyses showed a subtle advanced brain aging in young adults with formally diagnosed SPH. Taken together, these findings indicate the importance of clinical severity, impairment and persistence, and may suggest a slightly earlier end to maturational processes or subtle decline of brain structure in SPH.
特定恐惧症(SPH)是一种常见的焦虑症,可能涉及生物衰老加速。然而,精神病学领域的脑龄研究主要集中在情绪和精神障碍方面。这项大型分析在ENIGMA焦虑症工作组中对SPH参与者的脑衰老情况进行了调查。
使用FreeSurfer对来自17个国际样本(600名SPH个体,其中504名经正式诊断,96名基于问卷诊断;1134名对照;年龄范围:22至75岁)的3D脑结构MRI扫描进行处理。使用公开可用的ENIGMA脑龄模型从77个皮质下和皮质区域估计脑龄。脑预测年龄差异(brain-PAD)计算为脑龄减去实际年龄。线性混合效应模型检验了brain-PAD的组间差异以及年龄的调节作用。
未发现brain-PAD存在显著的组间差异((标准误)=0.37岁(0.43),P=0.39)。发现了诊断与年龄的负向交互作用,在经正式诊断的SPH中最为明显(=-0.08(0.03),P=0.02)。在排除患有焦虑共病、抑郁共病和正在使用药物的参与者后,这种交互作用仍然显著。事后分析显示,在年轻参与者(22至35岁)中,正式SPH诊断存在组间差异(=1.20(0.60),P<0.05,混合效应(95%置信区间)=0.14(0.00 - 0.28)),而在年长参与者(36至75岁)中则无差异(=0.07(0.65),P=0.91)。
在整个样本中,脑衰老与SPH无关。然而,在各项分析中均观察到诊断与年龄的交互作用,且在经正式诊断的SPH中最为强烈。事后分析显示,经正式诊断的年轻成年SPH患者存在轻微的脑衰老加速。综上所述,这些发现表明了临床严重程度、损害和持续性的重要性,并可能提示SPH患者成熟过程略有提前结束或脑结构出现轻微衰退。